- Home
- BHC vs PDO Comparison
BHC vs PDO Comparison
Compare BHC & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHC
- PDO
- Stock Information
- Founded
- BHC N/A
- PDO 2020
- Country
- BHC Canada
- PDO United States
- Employees
- BHC N/A
- PDO N/A
- Industry
- BHC Biotechnology: Pharmaceutical Preparations
- PDO Trusts Except Educational Religious and Charitable
- Sector
- BHC Health Care
- PDO Finance
- Exchange
- BHC Nasdaq
- PDO Nasdaq
- Market Cap
- BHC 2.2B
- PDO 1.8B
- IPO Year
- BHC N/A
- PDO N/A
- Fundamental
- Price
- BHC $6.24
- PDO $13.89
- Analyst Decision
- BHC Hold
- PDO
- Analyst Count
- BHC 2
- PDO 0
- Target Price
- BHC $9.00
- PDO N/A
- AVG Volume (30 Days)
- BHC 2.9M
- PDO 520.0K
- Earning Date
- BHC 10-29-2025
- PDO 01-01-0001
- Dividend Yield
- BHC N/A
- PDO 11.80%
- EPS Growth
- BHC N/A
- PDO N/A
- EPS
- BHC 0.97
- PDO N/A
- Revenue
- BHC $10,029,000,000.00
- PDO N/A
- Revenue This Year
- BHC $6.81
- PDO N/A
- Revenue Next Year
- BHC $4.11
- PDO N/A
- P/E Ratio
- BHC $6.47
- PDO N/A
- Revenue Growth
- BHC 5.86
- PDO N/A
- 52 Week Low
- BHC $4.25
- PDO $10.65
- 52 Week High
- BHC $8.69
- PDO $13.31
- Technical
- Relative Strength Index (RSI)
- BHC 47.14
- PDO 53.68
- Support Level
- BHC $5.91
- PDO $13.58
- Resistance Level
- BHC $6.15
- PDO $13.99
- Average True Range (ATR)
- BHC 0.25
- PDO 0.10
- MACD
- BHC -0.03
- PDO 0.01
- Stochastic Oscillator
- BHC 32.55
- PDO 79.79
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.